Find clinical trials for Multiple Sclerosis (MS) in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near San Francisco, CA, USA:
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Palo Alto, California, United States and 18 other locations
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP...
Phase 1, Phase 2
San Francisco, California, United States and 2 other locations
Newly diagnosed relapsing multiple sclerosis (MS) and high risk clinically isolated syndrome (CIS) patients will be treate...
Phase 4
San Francisco, California, United States
B cell-depleting therapies, such as ocrelizumab, are among the most effective medications currently available for the treatment of multiple ...
Phase 4
San Francisco, California, United States
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis...
Phase 1
Palo Alto, California, United States
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
San Francisco, California, United States and 107 other locations
(IV) (Part 1) and subcutaneous (SC) (Part 2) doses of RO7121932 and multiple ascending SC (Part 3) doses of RO7121932 in participants with m ...
Phase 1
Stanford, California, United States and 23 other locations
This study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple...
Phase 4
San Francisco, California, United States and 9 other locations
This study will evaluate the potential placental transfer of ocrelizumab in women with clinically isolated syndrome (CIS) or multiple sclerosis...
Phase 4
San Francisco, California, United States and 10 other locations
The goal of this study is to test a drug called KYV-101 in people who have progressive multiple sclerosis (MS) and who hav...
Phase 1
San Francisco, California, United States
Clinical trials
Research sites
Resources
Legal